09:51 AM EST - Valeant Pharmaceuticals International, Inc. : announced today that its board of directors has authorized a new securities repurchase program.. Under the Securities Repurchase Program, which commenced on November 22, 2013, the Company may make purchases of up to $1.5 billion of its convertible notes, senior notes, common shares and/or other debt or shares that may be issued prior to the completion of the program. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading up $0.07 at $150.24.
